Anticoagulation and bleeding risk in patients with COVID-19
N Musoke, KB Lo, J Albano, E Peterson, R Bhargav… - Thrombosis research, 2020 - Elsevier
Background There is no current standardized approach to anticoagulation in patients with
Coronavirus Disease 2019 (COVID-19) while potential bleeding risks remain. Our study
characterizes the patterns of anticoagulation use in COVID-19 patients and the risk of
related bleeding. Methods This is a single center retrospective analysis of 355 adult patients
with confirmed diagnosis of COVID-19 from March 1 to May 31, 2020. Chi-square was used
to analyze the relationship between degree of anticoagulant dose and bleeding events by …
Coronavirus Disease 2019 (COVID-19) while potential bleeding risks remain. Our study
characterizes the patterns of anticoagulation use in COVID-19 patients and the risk of
related bleeding. Methods This is a single center retrospective analysis of 355 adult patients
with confirmed diagnosis of COVID-19 from March 1 to May 31, 2020. Chi-square was used
to analyze the relationship between degree of anticoagulant dose and bleeding events by …
以上显示的是最相近的搜索结果。 查看全部搜索结果